Cooper Companies, Inc. (The) (COO) Shares Bought by Prudential Financial Inc.

Prudential Financial Inc. grew its position in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 1.8% during the third quarter, according to its most recent filing with the SEC. The firm owned 69,808 shares of the medical device company’s stock after acquiring an additional 1,240 shares during the period. Prudential Financial Inc. owned about 0.14% of Cooper Companies, Inc. (The) worth $16,552,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Advisory Services Network LLC grew its holdings in shares of Cooper Companies, Inc. (The) by 30.6% during the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after acquiring an additional 107 shares during the period. YorkBridge Wealth Partners LLC grew its stake in shares of Cooper Companies, Inc. (The) by 2.1% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after buying an additional 11 shares during the last quarter. Acrospire Investment Management LLC grew its stake in shares of Cooper Companies, Inc. (The) by 50.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after buying an additional 200 shares during the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Cooper Companies, Inc. (The) in the 3rd quarter worth approximately $163,000. Finally, Penserra Capital Management LLC grew its stake in shares of Cooper Companies, Inc. (The) by 13.0% in the 2nd quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock worth $211,000 after buying an additional 102 shares during the last quarter. Hedge funds and other institutional investors own 95.23% of the company’s stock.

Cooper Companies, Inc. (NYSE:COO) opened at $238.65 on Monday. The stock has a market capitalization of $11,680.00, a P/E ratio of 25.52, a P/E/G ratio of 2.05 and a beta of 0.55. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29.

Cooper Companies, Inc. (The) (NYSE:COO) last released its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.30 EPS. equities analysts anticipate that Cooper Companies, Inc. will post 9.72 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://sportsperspectives.com/2017/11/20/cooper-companies-inc-the-coo-shares-bought-by-prudential-financial-inc.html.

In related news, Director Gary S. Petersmeyer sold 3,977 shares of the company’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total value of $974,126.38. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 1.60% of the company’s stock.

Several research firms recently weighed in on COO. BidaskClub downgraded Cooper Companies, Inc. (The) from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Jefferies Group LLC restated a “buy” rating and issued a $250.00 price target on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Stephens restated an “equal weight” rating and issued a $250.00 price target (up previously from $235.00) on shares of Cooper Companies, Inc. (The) in a research note on Tuesday, September 12th. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $265.00 price target on the stock in a research note on Tuesday, October 10th. Finally, KeyCorp restated a “hold” rating on shares of Cooper Companies, Inc. (The) in a research note on Monday, August 28th. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $260.22.

Cooper Companies, Inc. (The) Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply